GL1X · GenesisL1 explorer

Research workbench

Cryo-EM structure of human cpsf-160-WDR33 complex at 3.8 a resolution

Analyse Cryo-EM structure of human cpsf-160-WDR33 complex at 3.8 a resolution in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BM0
Type
protein
Length
1,538 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cleavage and polyadenylation specificity factor subunit 1; Pre-mRNA 3' end processing…
UniProt
Q10570, Q9C0J8
Pockets
15 · best druggability 0.88

Structure

electron microscopy · 2 distinct chains · 5% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACleavage and polyadenylation specificity factor subunit 1protein11755% helix, 43% strandQ10570
BPre-mRNA 3' end processing protein WDR33protein3634% helix, 34% strandQ9C0J8

Pockets

15 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18630.880.91101empty
211320.860.87114empty
35830.840.9053empty
48450.800.8361empty
56360.770.8253empty

Interfaces

1 interface between chains.

  • A–B · 3828 Ų buried · 35 hydrogen bonds · protein-protein

Compared structures

  • 6BM0 · Cryo-EM structure of human CPSF-160-WDR33 complex at 3.8 A resolution · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9C0J8 · AlphaFold monomer V2.0 prediction for pre-mRNA 3' end processing protein WDR33 (Q9C0J8) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • Q10570 · AlphaFold monomer V2.0 prediction for cleavage and polyadenylation specificity factor… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.